박사

Comprehensive characterization of mesenchymal stem cells from human adipose tissue and amniotic membrane

김선희 2015년
논문상세정보
' Comprehensive characterization of mesenchymal stem cells from human adipose tissue and amniotic membrane' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • amniotic membrane
  • characterization
  • mssenchymal stem cells
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
195 0

0.0%

' Comprehensive characterization of mesenchymal stem cells from human adipose tissue and amniotic membrane' 의 참고문헌

  • Z. Miao, J. Jin, L. Chen, J. Zhu, W. Huang, J. Zhao, H. Qian,X. Zhang: Isolation of mesenchymal stem cells from humanplacenta: comparison with human bone marrowmesenchymal stem cells. Cell Biol Int 2006, 30:681-687.
  • Y.D. Halvorsen, D. Franklin, A.L. Bond, D.C. Hitt, C. Auchter,A.L. Boskey, E.P. Paschalis, W.O. Wilkison, J.M. Gimble:Extracellular matrix mineralization and osteoblast geneexpression by human adipose tissue-derived stromal cells.Tissue Eng 2001, 7:729-741.
  • Y. Wei, Y. Li, C. Chen, K. Stoelzel, A.M. Kaufmann, A.E.Albers: Human skeletal muscle-derived stem cells retainstem cell properties after expansion in myosphere culture.Exp Cell Res 2011, 317:1016-1027.
  • Y. Sakaguchi, I. Sekiya, K. Yagishita, T. Muneta: Comparisonof human stem cells derived from various mesenchymaltissues: superiority of synovium as a cell source. ArthritisRheum 2005, 52:2521-2529.
  • W.L. Cheng, C.S. Wang, Y.H. Huang, M.M. Tsai, Y. Liang,K.H. Lin: Overexpression of CXCL1 and its receptorCXCR2 promote tumor invasion in gastric cancer. AnnOncol 2011, 22:2267-2276.
  • W.J. Jurgens, M.J. Oedayrajsingh-Varma, M.N. Helder, B.Zandiehdoulabi, T.E. Schouten, D.J. Kuik, M.J. Ritt, F.J. vanMilligen: Effect of tissue-harvesting site on yield of stemcells derived from adipose tissue: implications for cellbasedtherapies. Cell Tissue Res 2008, 332:415-426.
  • V. Van Harmelen, K. Rohrig, H. Hauner: Comparison ofproliferation and differentiation capacity of humanadipocyte precursor cells from the omental andsubcutaneous adipose tissue depot of obese subjects.Metabolism 2004, 53:632-637.78
  • T. Tamagawa, S. Oi, I. Ishiwata, H. Ishikawa, Y. Nakamura:Differentiation of mesenchymal cells derived from humanamniotic membranes into hepatocyte-like cells in vitro.Hum Cell 2007, 20:77-84.82
  • T. Kinnaird, E. Stabile, M.S. Burnett, M. Shou, C.W. Lee, S.Barr, S. Fuchs, S.E. Epstein: Local delivery of marrowderivedstromal cells augments collateral perfusionthrough paracrine mechanisms. Circulation 2004,109:1543-1549.
  • S.K. Kang, I.S. Shin, M.S. Ko, J.Y. Jo, J.C. Ra: Journey ofmesenchymal stem cells for homing: strategies to enhanceefficacy and safety of stem cell therapy. Stem Cells Int2012:342968.
  • S.H. Kim, S.H. Bang, S.A. Park, S.Y. Kang, K.D. Park, I.U.Oh, S.H. Yoo, H. Kim, C.H. Kim, S.Y. Baek: Charactercomparison of abdomen-derived and eyelid-derivedmesenchymal stem cells. Cell Prolif 2013, 46:291-299.
  • S. Meirelles Lda, A.M. Fontes, D.T. Covas, A.I. Caplan:Mechanisms involved in the therapeutic properties ofmesenchymal stem cells. Cytokine Growth Factor Rev 2009,20:419-427.83
  • S. Gronthos, D.M. Franklin, H.A. Leddy, P.G. Robey, R.W.Storms, J.M. Gimble: Surface protein characterization ofhuman adipose tissue-derived stromal cells. J Cell Physiol2001, 189:54-63.
  • S. Diaz-Prado, E. Muinos-Lopez, T. Hermida-Gomez, M.E.Rendal-Vazquez, I. Fuentes-Boquete, F.J. de Toro, F.J. Blanco:Multilineage differentiation potential of cells isolated fromthe human amniotic membrane. J Cell Biochem 2010,111:846-857.
  • S. Diaz-Prado, E. Muinos-Lopez, T. Hermida-Gomez, C.Cicione, M.E. Rendal-Vazquez, I. Fuentes-Boquete, F.J. deToro, F.J. Blanco: Human amniotic membrane as analternative source of stem cells for regenerative medicine.85Differentiation 2011, 81:162-171.
  • S. Baglioni, M. Francalanci, R. Squecco, A. Lombardi, G.Cantini, R. Angeli, S. Gelmini, D. Guasti, S. Benvenuti, F.Annunziato, D. Bani, F. Liotta, F. Francini, G. Perigli, M.Serio, M. Luconi: Characterization of human adult stemcellpopulations isolated from visceral and subcutaneousadipose tissue. FASEB J 2009, 23:3494-3505.
  • R.M. Dwyer, S.M. Potter-Beirne, K.A. Harrington, A.J.Lowery, E. Hennessy, J.M. Murphy, F.P. Barry, T. O'Brien, M.J.Kerin: Monocyte chemotactic protein-1 secreted byprimary breast tumors stimulates migration ofmesenchymal stem cells. Clin Cancer Res 2007, 13:5020-5027.
  • R. Vishnubalaji, M. Al-Nbaheen, B. Kadalmani, A. Aldahmash,T. Ramesh: Comparative investigation of the differentiationcapability of bone-marrow- and adipose-derivedmesenchymal stem cells by qualitative and quantitativeanalysis. Cell Tissue Res 2012, 347:419-427.
  • R. Ogawa, H. Mizuno, A. Watanabe, M. Migita, H.Hyakusoku, T. Shimada: Adipogenic differentiation byadipose-derived stem cells harvested from GFP transgenicmice-including relationship of sex differences. BiochemBiophys Res Commun 2004, 319:511-517.
  • R. Benelli, S. Stigliani, S. Minghelli, S. Carlone, N. Ferrari:Impact of CXCL1 overexpression on growth and invasionof prostate cancer cell. Prostate 2013, 73:941-951.
  • P.S. In 't Anker, S.A. Scherjon, C. Kleijburg-van der Keur,G.M. de Groot-Swings, F.H. Claas, W.E. Fibbe, H.H. Kanhai:Isolation of mesenchymal stem cells of fetal or maternalorigin from human placenta. Stem Cells 2004, 22:1338-1345.
  • P.C. Wrage, T. Tran, K. To, E.W. Keefer, K.A. Ruhn, J. Hong,S. Hattangadi, I. Trevino, M.G. Tansey: The neuro-glialproperties of adipose-derived adult stromal (ADAS) cellsare not regulated by Notch 1 and are not derived from81neural crest lineage. PLoS One 2008, 3:e1453.
  • P.A. Zuk, M. Zhu, P. Ashjian, D.A. De Ugarte, J.I. Huang, H.Mizuno, Z.C. Alfonso, J.K. Fraser, P. Benhaim, M.H. Hedrick:Human adipose tissue is a source of multipotent stem cells.Mol Biol Cell 2002, 13:4279-4295.
  • P.A. Zuk, M. Zhu, H. Mizuno, J. Huang, J.W. Futrell, A.J.Katz, P. Benhaim, H.P. Lorenz, M.H. Hedrick: Multilineagecells from human adipose tissue: implications for cellbasedtherapies. Tissue Eng 2001, 7:211-228.
  • P. Zhao, H. Ise, M. Hongo, M. Ota, I. Konishi, T. Nikaido:Human amniotic mesenchymal cells have somecharacteristics of cardiomyocytes. Transplantation 2005,79:528-535.
  • O. Parolini, F. Alviano, G.P. Bagnara, G. Bilic, H.J. Buhring,M. Evangelista, S. Hennerbichler, B. Liu, M. Magatti, N. Mao,T. Miki, F. Marongiu, H. Nakajima, T. Nikaido, C.B.Portmann-Lanz, V. Sankar, M. Soncini, G. Stadler, D. Surbek,T.A. Takahashi, H. Redl, N. Sakuragawa, S. Wolbank, S.Zeisberger, A. Zisch, S.C. Strom: Concise review: isolationand characterization of cells from human term placenta:outcome of the first international Workshop on PlacentaDerived Stem Cells. Stem Cells 2008, 26:300-311.
  • N. Sakuragawa, K. Kakinuma, A. Kikuchi, H. Okano, S.Uchida, I. Kamo, M. Kobayashi, Y. Yokoyama: Humanamnion mesenchyme cells express phenotypes of neuroglialprogenitor cells. J Neurosci Res 2004, 78:208-214.
  • M. Soncini, E. Vertua, L. Gibelli, F. Zorzi, M. Denegri, A.Albertini, G.S. Wengler, O. Parolini: Isolation andcharacterization of mesenchymal cells from human fetalmembranes. J Tissue Eng Regen Med 2007, 1:296-305.
  • M. Ohyama, A. Terunuma, C.L. Tock, M.F. Radonovich, C.A.77Pise-Masison, S.B. Hopping, J.N. Brady, M.C. Udey, J.C.Vogel: Characterization and isolation of stem cell-enrichedhuman hair follicle bulge cells. J Clin Invest 2006, 116:249-260.
  • M. Miura, S. Gronthos, M. Zhao, B. Lu, L.W. Fisher, P.G.Robey, S. Shi: SHED: stem cells from human exfoliateddeciduous teeth. Proc Natl Acad Sci USA 2003, 100:5807-5812.
  • M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F.Marini, D. Krause, R. Deans, A. Keating, D. Prockop, E.Horwitz: Minimal criteria for defining multipotentmesenchymal stromal cells. The International Society forCellular Therapy position statement. Cytotherapy 2006,8:315-317.
  • L. Zimmerlin, A.D. Donnenberg, J.P. Rubin, P. Basse, R.J.Landreneau, V.S. Donnenberg: Regenerative therapy andcancer: in vitro and in vivo studies of the interactionbetween adipose-derived stem cells and breast cancer cellsfrom clinical isolates. Tissue Eng Part A 2011, 17:93-106.
  • L. Prantl, F. Muehlberg, N.M. Navone, Y.H. Song, J. Vykoukal,C.J. Logothetis, E.U. Alt: Adipose tissue-derived stem cellspromote prostate tumor growth. Prostate 2010, 70:1709-1715.
  • K. Bieback, A. Hecker, T. Schlechter, I. Hofmann, N. Brousos,T. Redmer, D. Besser, H. Kluter, A.M. Muller, M. Becker:Replicative aging and differentiation potential of humanadipose tissue-derived mesenchymal stromal cellsexpanded in pooled human or fetal bovine serum.Cytotherapy 2012, 14:570-583.
  • J.R. Smith, O.M. Pereira-Smith: Replicative senescence:implications for in vivo aging and tumor suppression.Science 1996, 273:63-67.
  • J.P. Wei, T.S. Zhang, S. Kawa, T. Aizawa, M. Ota, T. Akaike,K. Kato, I. Konishi, T. Nikaido: Human amnion-isolatedcells normalize blood glucose in streptozotocin-induceddiabetic mice. Cell Transplant 2003, 12:545-552.
  • J.M. Gimble, A.J. Katz, B.A. Bunnell: Adipose-derived stemcells for regenerative medicine. Circ Res 2007, 100:1249-1260.
  • J.K. Singh, G. Farnie, N.J. Bundred, B.M. Simoes, A. Shergill,G. Landberg, S.J. Howell, R.B. Clarke: Targeting CXCR1/2significantly reduces breast cancer stem cell activity andincreases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms. Clin Cancer Res2013, 19:643-656.
  • J.K. Fraser, I. Wulur, Z. Alfonso, M.H. Hedrick: Fat tissue: anunderappreciated source of stem cells for biotechnology.Trends Biotechnol 2006, 24:150-154.
  • J.K. Fraser, I. Wulur, Z. Alfonso, M. Zhu, E.S. Wheeler:Differences in stem and progenitor cell yield in differentsubcutaneous adipose tissue depots. Cytotherapy 2007,9:459-467.
  • J.I. Huang, P.A. Zuk, N.F. Jones, M. Zhu, H.P. Lorenz, M.H.Hedrick, P. Benhaim: Chondrogenic potential ofmultipotential cells from human adipose tissue. PlastReconstr Surg 2004, 113:585-594.
  • J.B. Mitchell, K. McIntosh, S. Zvonic, S. Garrett, Z.E. Floyd,A. Kloster, Y. Di Halvorsen, R.W. Storms, B. Goh, G. Kilroy,X. Wu, J.M. Gimble: Immunophenotype of human adiposederivedcells: temporal changes in stromal-associated andstem cell-associated markers. Stem Cells 2006, 24:376-385.80
  • J. Rehman, D. Traktuev, J. Li, S. Merfeld-Clauss, C.J. Temm-Grove, J.E. Bovenkerk, C.L. Pell, B.H. Johnstone, R.V.Considine, K.L. March: Secretion of angiogenic andantiapoptotic factors by human adipose stromal cells.Circulation 2004, 109:1292-1298.
  • J. Kim, Y. Lee, H. Kim, K.J. Hwang, H.C. Kwon, S.K. Kim,D.J. Cho, S.G. Kang, J. You: Human amniotic fluid-derivedstem cells have characteristics of multipotent stem cells.Cell Prolif 2007, 40:75-90.
  • I.A. Droujinine, M.A. Eckert, W. Zhao: To grab the stromaby the horns: from biology to cancer therapy withmesenchymal stem cells. Oncotarget 2013, 4:651-664.
  • H.M. Kang, J. Kim, S. Park, H. Kim, K.S. Kim, E.J. Lee, S.I.Seo, S.G. Kang, J.E. Lee, H. Lim: Insulin-secreting cellsfrom human eyelid-derived stem cells alleviate type Idiabetes in immunocompetent mice. Stem Cells 2009,27:1999-2008.
  • H.J. Buhring, S. Treml, F. Cerabona, P. de Zwart, L. Kanz, M.Sobiesiak: Phenotypic characterization of distinct humanbone marrow-derived MSC subsets. Ann N Y Acad Sci 2009,1176:124-134.
  • H. Suga, H. Eto, T. Shigeura, K. Inoue, N. Aoi, H. Kato, S.Nishimura, I. Manabe, K. Gonda, K. Yoshimura: IFATScollection: Fibroblast growth factor-2-induced hepatocytegrowth factor secretion by adipose-derived stromal cellsinhibits postinjury fibrogenesis through a c-Jun Nterminalkinase-dependent mechanism. Stem Cells 2009,27:238-249.
  • H. Nam, G. Lee: Identification of novel epithelial stem celllikecells in human deciduous dental pulp. Biochem BiophysRes Commun 2009, 386:135-139.
  • H. Nakagami, R. Morishita, K. Maeda, Y. Kikuchi, T. Ogihara,Y. Kaneda: Adipose tissue-derived stromal cells as a noveloption for regenerative cell therapy. J Atheroscler Thromb2006, 13:77-81.
  • H. Egusa, K. Iida, M. Kobayashi, T.Y. Lin, M. Zhu, P.A. Zuk,C.J. Wang, D.K. Thakor, M.H. Hedrick, I. Nishimura:Downregulation of extracellular matrix-related geneclusters during osteogenic differentiation of human bonemarrow- and adipose tissue-derived stromal cells. TissueEng 2007, 13:2589-2600.
  • F.T. Martin, R.M. Dwyer, J. Kelly, S. Khan, J.M. Murphy, C.Curran, N. Miller, E. Hennessy, P. Dockery, F.P. Barry, T.O'Brien, M.J. Kerin: Potential role of mesenchymal stemcells (MSCs) in the breast tumour microenvironment:stimulation of epithelial to mesenchymal transition (EMT).87Breast Cancer Res Treat 2010, 124:317-326.
  • F. Jenhani, V. Durand, N. Ben Azouna, S. Thallet, T. BenOthmen, M. Bejaoui, J. Domenech: Human cytokineexpression profile in various conditioned media for in vitroexpansion bone marrow and umbilical cord bloodimmunophenotyped mesenchymal stem cells. TransplantProc 2011, 43:639-643.
  • F. Alviano, V. Fossati, C. Marchionni, M. Arpinati, L. Bonsi,M. Franchina, G. Lanzoni, S. Cantoni, C. Cavallini, F. Bianchi,P.L. Tazzari, G. Pasquinelli, L. Foroni, C. Ventura, A. Grossi,G.P. Bagnara: Term Amniotic membrane is a highthroughput source for multipotent Mesenchymal StemCells with the ability to differentiate into endothelial cellsin vitro. BMC Dev Biol 2007, 7:11.
  • E.M. Horwitz, K. Le Blanc, M. Dominici, I. Mueller, I. Slaper-Cortenbach, F.C. Marini, R.J. Deans, D.S. Krause, A. Keating:Clarification of the nomenclature for MSC: TheInternational Society for Cellular Therapy positionstatement. Cytotherapy 2005, 7:393-395.
  • D.S. Kim, J.H. Kim, J.K. Lee, S.J. Choi, J.S. Kim, S.S. Jeun,W. Oh, Y.S. Yang, J.W. Chang: Overexpression of CXCchemokine receptors is required for the superior gliomatrackingproperty of umbilical cord blood-derivedmesenchymal stem cells. Stem Cells Dev 2009, 18:511-519.
  • D. Peroni, I. Scambi, A. Pasini, V. Lisi, F. Bifari, M. Krampera,G. Rigotti, A. Sbarbati, M. Galie: Stem molecular signatureof adipose-derived stromal cells. Exp Cell Res 2008,314:603-615.
  • D. Hanahan, R.A. Weinberg: Hallmarks of cancer: the nextgeneration. Cell 2011, 144:646-674.
  • D. Campioni, S. Moretti, L. Ferrari, M. Punturieri, G.L.Castoldi, F. Lanza: Immunophenotypic heterogeneity ofbone marrow-derived mesenchymal stromal cells frompatients with hematologic disorders: correlation with bonemarrow microenvironment. Haematologica 2006, 91:364-79368.
  • D. Campioni, F. Lanza, S. Moretti, L. Ferrari, A. Cuneo: Lossof Thy-1 (CD90) antigen expression on mesenchymalstromal cells from hematologic malignancies is induced byin vitro angiogenic stimuli and is associated with peculiarfunctional and phenotypic characteristics. Cytotherapy2005, 10:69-82.
  • C.H. Liu, S.M. Hwang: Cytokine interactions inmesenchymal stem cells from cord blood. Cytokine 2005,32:270-279.86
  • C.B. Portmann-Lanz, A. Schoeberlein, A. Huber, R. Sager, A.Malek, W. Holzgreve, D.V. Surbek: Placental mesenchymal84stem cells as potential autologous graft for pre- andperinatal neuroregeneration. Am J Obstet Gynecol 2006,194:664-673.
  • C. Ventura, S. Cantoni, F. Bianchi, V. Lionetti, C. Cavallini, I.Scarlata, L. Foroni, M. Maioli, L. Bonsi, F. Alviano, V. Fossati,G.P. Bagnara, G. Pasquinelli, F.A. Recchia, A. Perbellini:Hyaluronan mixed esters of butyric and retinoic Acid drivecardiac and endothelial fate in term placenta humanmesenchymal stem cells and enhance cardiac repair ininfarcted rat hearts. J Biol Chem 2007, 282:14243-14252.
  • B. Zavan, V. Vindigni, C. Gardin, D. D'Avella, A. Della Puppa,G. Abatangelo, R. Cortivo: Neural potential of adipose stemcells. Discov Med 2010, 10:37-43.
  • A.Y. Khakoo, S. Pati, S.A. Anderson, W. Reid, M.F. Elshal,Rovira, II, A.T. Nguyen, D. Malide, C.A. Combs, G. Hall, J.Zhang, M. Raffeld, T.B. Rogers, W. Stetler-Stevenson, J.A.Frank, M. Reitz, T. Finkel: Human mesenchymal stem cellsexert potent antitumorigenic effects in a model of Kaposi'ssarcoma. J Exp Med 2006, 203:1235-1247.
  • A.V. Shakhbazau, N.V. Goncharova, S.M. Kosmacheva, N.A.Kartel, M.P. Potapnev: Plasticity of human mesenchymalstem cell phenotype and expression profile underneurogenic conditions. Bull Exp Biol Med 2009, 147:513-516.
  • A.H. Klopp, A. Gupta, E. Spaeth, M. Andreeff, F. Marini:Concise review: Dissecting a discrepancy in the literature:do mesenchymal stem cells support or suppress tumorgrowth? Stem Cells 2011, 29:11-19.
  • A.E. Karnoub, A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks,G.W. Bell, A.L. Richardson, K. Polyak, R. Tubo, R.A.Weinberg: Mesenchymal stem cells within tumour stromapromote breast cancer metastasis. Nature 2007, 449:557-563.
  • A. Trounson, R.G. Thakar, G. Lomax, D. Gibbons: Clinicaltrials for stem cell therapies. BMC Med. 2001, 9:52.